These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33839702)

  • 1. NET1 promotes HCC growth and metastasis
    Chen ZH; Ni QZ; Zhang XP; Ma N; Feng JK; Wang K; Li JJ; Xie D; Ma XY; Cheng SQ
    Aging (Albany NY); 2021 Apr; 13(7):10672-10687. PubMed ID: 33839702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma.
    Ye K; Chang S; Li J; Li X; Zhou Y; Wang Z
    Tumour Biol; 2014 Nov; 35(11):11219-27. PubMed ID: 25113254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
    Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X
    Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
    Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
    Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
    Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway.
    Tang L; Xu S; Wei R; Fan G; Zhou J; Wei X; Xu X
    Mol Med; 2024 Jul; 30(1):108. PubMed ID: 39060928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway.
    Zhang J; Shi Y; Ding K; Yu W; He J; Sun B
    J Exp Clin Cancer Res; 2024 May; 43(1):136. PubMed ID: 38711082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway.
    Huang QB; Zhang HW; Liao ZB
    Curr Med Sci; 2019 Oct; 39(5):727-733. PubMed ID: 31612389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
    Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
    BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway.
    Zhao G; Shi X; Sun Z; Zhao P; Lu Z
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1602-1613. PubMed ID: 34718369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.
    Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X
    Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway.
    Chen L; Liu D; Yi X; Qi L; Tian X; Sun B; Dong Q; Han Z; Li Q; Song T; Guo M; Zhang W; Guo H; Zhang T
    Cell Death Dis; 2020 May; 11(5):320. PubMed ID: 32371982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
    Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
    Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nogo-B receptor promotes human hepatocellular carcinoma cell growth via the Akt signal pathway.
    Dong C; Liu Y; Jiang K; Wang H; Qu W; Zhang C; Liang R; Gao Z; Zhao B; Miao Q; Shao S; Wang L
    J Cell Biochem; 2018 Sep; 119(9):7738-7746. PubMed ID: 29904947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.